IL155886A0 - Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings - Google Patents
Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedingsInfo
- Publication number
- IL155886A0 IL155886A0 IL15588601A IL15588601A IL155886A0 IL 155886 A0 IL155886 A0 IL 155886A0 IL 15588601 A IL15588601 A IL 15588601A IL 15588601 A IL15588601 A IL 15588601A IL 155886 A0 IL155886 A0 IL 155886A0
- Authority
- IL
- Israel
- Prior art keywords
- factor vii
- coagulation factor
- activated coagulation
- thrombolytic therapy
- bleedings
- Prior art date
Links
- 208000032843 Hemorrhage Diseases 0.000 title abstract 3
- 208000034158 bleeding Diseases 0.000 title abstract 3
- 231100000319 bleeding Toxicity 0.000 title abstract 3
- 230000000740 bleeding effect Effects 0.000 title abstract 3
- 108010023321 Factor VII Proteins 0.000 title abstract 2
- 239000003146 anticoagulant agent Substances 0.000 title abstract 2
- 229940105772 coagulation factor vii Drugs 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 230000002537 thrombolytic effect Effects 0.000 title abstract 2
- 102000016519 Coagulation factor VII Human genes 0.000 title 1
- 102100023804 Coagulation factor VII Human genes 0.000 abstract 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 abstract 1
- 239000003527 fibrinolytic agent Substances 0.000 abstract 1
- 230000003480 fibrinolytic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00128252A EP1216709A1 (en) | 2000-12-21 | 2000-12-21 | Use of activated coagulation factor VII for treating thrombolytic therapy-induced major bleedings |
| PCT/EP2001/015132 WO2002049665A2 (en) | 2000-12-21 | 2001-12-20 | Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155886A0 true IL155886A0 (en) | 2003-12-23 |
Family
ID=8170769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15588601A IL155886A0 (en) | 2000-12-21 | 2001-12-20 | Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20040087502A1 (cs) |
| EP (2) | EP1216709A1 (cs) |
| JP (1) | JP2004516273A (cs) |
| KR (1) | KR20030063454A (cs) |
| CN (1) | CN1482919A (cs) |
| AT (1) | ATE353666T1 (cs) |
| AU (2) | AU2638602A (cs) |
| BR (1) | BR0116151A (cs) |
| CA (1) | CA2431986A1 (cs) |
| CY (1) | CY1106363T1 (cs) |
| CZ (1) | CZ300670B6 (cs) |
| DE (1) | DE60126650T2 (cs) |
| DK (1) | DK1343523T3 (cs) |
| EC (1) | ECSP034647A (cs) |
| ES (1) | ES2280429T3 (cs) |
| HU (1) | HUP0302574A3 (cs) |
| IL (1) | IL155886A0 (cs) |
| MX (1) | MXPA03005641A (cs) |
| NZ (1) | NZ549850A (cs) |
| PL (1) | PL205878B1 (cs) |
| PT (1) | PT1343523E (cs) |
| RU (1) | RU2286796C2 (cs) |
| SI (1) | SI1343523T1 (cs) |
| WO (1) | WO2002049665A2 (cs) |
| ZA (1) | ZA200304140B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005123118A1 (en) * | 2004-06-21 | 2005-12-29 | Novo Nordisk Health Care Ag | Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) |
| RU2396086C2 (ru) * | 2004-09-10 | 2010-08-10 | Фармаоригин Апс | Способы лечения трахеального, бронхиального или альвеолярного кровотечения или кровохарканья |
| US20090156481A1 (en) * | 2005-07-15 | 2009-06-18 | Novo Nordisk Healthcare A/G | Use of Factor VIIa or Factor VIIa Equivalents for Preventing or Attenuating Haemorrhage Growth, and/or Oedema Generation Following Intracerebral Haemorrhage (ICH) in Patients Treated with Antiplatelet Therapy |
| JP2011509978A (ja) | 2008-01-18 | 2011-03-31 | ノボ ノルディスク ヘルス ケア アーゲー | 選択されたＩＣＨ患者亜集団における脳内出血（ＩＣＨ）後の出血拡大、及び／又は浮腫生成の予防又は減弱のための、第ＶＩＩａ因子又は第ＶＩＩａ因子等価物の使用 |
| RU2552339C1 (ru) * | 2014-02-19 | 2015-06-10 | Общество с ограниченной ответственностью фирма "Технология-Стандарт" | Способ профилактики кровотечений, вызванных применением стрептокиназы, в эксперименте |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4382082A (en) * | 1980-12-18 | 1983-05-03 | Uop Inc. | Recovery of cobalt values by absorption from ammoniacal solution |
| ZA862768B (en) * | 1985-04-17 | 1986-12-30 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
| US5374617A (en) * | 1992-05-13 | 1994-12-20 | Oklahoma Medical Research Foundation | Treatment of bleeding with modified tissue factor in combination with FVIIa |
| US5846517A (en) * | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
| AU7907398A (en) * | 1997-06-23 | 1999-01-04 | Novo Nordisk A/S | Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function |
-
2000
- 2000-12-21 EP EP00128252A patent/EP1216709A1/en not_active Withdrawn
-
2001
- 2001-12-20 ES ES01995705T patent/ES2280429T3/es not_active Expired - Lifetime
- 2001-12-20 DK DK01995705T patent/DK1343523T3/da active
- 2001-12-20 MX MXPA03005641A patent/MXPA03005641A/es active IP Right Grant
- 2001-12-20 PT PT01995705T patent/PT1343523E/pt unknown
- 2001-12-20 DE DE60126650T patent/DE60126650T2/de not_active Expired - Lifetime
- 2001-12-20 EP EP01995705A patent/EP1343523B1/en not_active Expired - Lifetime
- 2001-12-20 PL PL361855A patent/PL205878B1/pl not_active IP Right Cessation
- 2001-12-20 KR KR10-2003-7008408A patent/KR20030063454A/ko not_active Ceased
- 2001-12-20 BR BR0116151-2A patent/BR0116151A/pt not_active Application Discontinuation
- 2001-12-20 JP JP2002551003A patent/JP2004516273A/ja active Pending
- 2001-12-20 SI SI200130694T patent/SI1343523T1/sl unknown
- 2001-12-20 IL IL15588601A patent/IL155886A0/xx not_active IP Right Cessation
- 2001-12-20 AT AT01995705T patent/ATE353666T1/de not_active IP Right Cessation
- 2001-12-20 NZ NZ549850A patent/NZ549850A/en unknown
- 2001-12-20 CZ CZ20031743A patent/CZ300670B6/cs not_active IP Right Cessation
- 2001-12-20 HU HU0302574A patent/HUP0302574A3/hu unknown
- 2001-12-20 RU RU2003122362/15A patent/RU2286796C2/ru not_active IP Right Cessation
- 2001-12-20 WO PCT/EP2001/015132 patent/WO2002049665A2/en not_active Ceased
- 2001-12-20 AU AU2638602A patent/AU2638602A/xx active Pending
- 2001-12-20 CA CA002431986A patent/CA2431986A1/en not_active Abandoned
- 2001-12-20 US US10/451,615 patent/US20040087502A1/en not_active Abandoned
- 2001-12-20 CN CNA018211119A patent/CN1482919A/zh active Pending
- 2001-12-20 AU AU2002226386A patent/AU2002226386B2/en not_active Ceased
-
2003
- 2003-05-28 ZA ZA200304140A patent/ZA200304140B/en unknown
- 2003-06-11 EC EC2003004647A patent/ECSP034647A/es unknown
-
2007
- 2007-03-08 CY CY20071100327T patent/CY1106363T1/el unknown
-
2008
- 2008-07-10 US US12/170,916 patent/US20080286259A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1997047296A3 (en) | Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies | |
| PT1039887E (pt) | Metodos para o tratamento de neuro e nefro disturbios e de toxicidades terapeuticas usando compostos de aminotiol | |
| WO2001078711A3 (en) | Pde-v inhibitors for treatment of parkinson's disease | |
| PL365285A1 (en) | Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs | |
| MXPA06003163A (es) | Combinacion de un inhibidor de receptor de vegf con un agente quimioterapeutico. | |
| AU2002321105A1 (en) | Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis | |
| EA200200306A1 (ru) | Трициклические ингибиторы поли(адф-рибозо)полимераз | |
| CY1107054T1 (el) | Ενωσεις διτοσυλικου αλατος κιναζολινης | |
| WO2004110380A3 (en) | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents | |
| NO20021035D0 (no) | Fremgangsmåter for anvendelse av rasktvirkende selektive serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon | |
| WO2000018439A3 (de) | Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren | |
| AU2638602A (en) | Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings | |
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| CA2461117A1 (en) | Botulinus toxin for treatment of body odour | |
| ATE402694T1 (de) | Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz | |
| DE69836783D1 (de) | Methode zur Behandlung des Tourette-Syndroms | |
| WO2003053999A3 (de) | Selektive arylguanidinpeptide als urokinaseinhibitoren | |
| BG108451A (en) | Use of il-18 inhibitors for treating or preventing cns injuries | |
| ATE545423T1 (de) | Mittel zur behandlung von lungenkrebs | |
| WO2002039958A3 (en) | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents | |
| BR0115881A (pt) | Emprego de compostos ciclohexanona substituìdos de 6-dimetilaminometil-1-fenil para a terapia da incontinência urinária | |
| WO2004026252A3 (en) | Glioma treatments | |
| AU6755301A (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites | |
| ATE271867T1 (de) | Behandlung der harninkontinenz und zusammenstellung dafür |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |